Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide

被引：102
|
作者：
Van Camp, G
Flamez, A
Cosyns, B
Goldstein, J
Perdaens, C
Schoors, D
机构：
[1] Free Univ Brussels, Akad Ziekenhuis, Dept Cardiol, B-1090 Brussels, Belgium
[2] Free Univ Brussels, Dept Neurol, B-1090 Brussels, Belgium
[3] Free Univ Brussels, Dept Cardiac Surg, B-1090 Brussels, Belgium
[4] Free Univ Brussels, Dept Pathol, B-1090 Brussels, Belgium
来源：
NEUROLOGY | 2003年 / 61卷 / 06期
关键词：
D O I：
10.1212/01.WNL.0000083985.00343.F2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The authors report the clinical, echocardiographic, and pathologic findings in two patients treated with more than 5 mg of pergolide daily who developed symptomatic severe heart failure due to restrictive valvular disease. They also describe the echocardiographic data of another eight patients taking similar doses of pergolide presenting no clinical signs of heart failure. The findings suggest a possible role of high doses of pergolide in inducing restrictive valvular disease.
引用
收藏
页码：859 / 861
页数：3
相关论文
共 50 条
  • [31] Pergolide and valvular heart disease: the lower the better?
    Droogmans, Steven
    Cosyns, Bernard
    Van Camp, Guy
    [J]. EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2008, 9 (06): : 717 - 718
  • [32] Pergolide pharmacokinetics in patients with Parkinson's disease
    Thalamas, C
    Rascol, O
    Blin, O
    Kulisevsky, J
    Rajman, I
    Brefel-Courbon, C
    [J]. MOVEMENT DISORDERS, 2002, 17 : S47 - S47
  • [33] Dopamine agonists and valvular heart disease on Japanese patients with Parkinson's disease
    Nagai, Masahiro
    Nishikawa, Noriko
    Yabe, Hayato
    Moritoyo, Hiroyoko
    Moritoyo, Takashi
    Shigematsu, Yuji
    Nomoto, Masahiro
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 (Suppl 4) : 54 - 57
  • [34] Dopamine agonists and valvular heart disease in Japanese patients with Parkinson's disease
    Masahiro Nagai
    Noriko Nishikawa
    Hayato Yabe
    Hiroyoko Moritoyo
    Takashi Moritoyo
    Yuji Shigematsu
    Masahiro Nomoto
    [J]. Journal of Neurology, 2007, 254 : IV54 - IV57
  • [35] High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson’s disease
    Tomoko Oeda
    Motoko Masaki
    Kenji Yamamoto
    Eiji Mizuta
    Naoyuki Kitagawa
    Tsuyoshi Isono
    Satoshi Taniguchi
    Kiyoshi Doi
    Hitoshi Yaku
    Chikao Yutani
    Takashi Kawamura
    Sadako Kuno
    Hideyuki Sawada
    [J]. Journal of Neural Transmission, 2009, 116
  • [36] High-dose paraquat exposure and Parkinson's disease
    Brent, Jeffrey
    [J]. NEUROTOXICOLOGY, 2013, 37 : 247 - 247
  • [37] High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease
    Oeda, Tomoko
    Masaki, Motoko
    Yamamoto, Kenji
    Mizuta, Eiji
    Kitagawa, Naoyuki
    Isono, Tsuyoshi
    Taniguchi, Satoshi
    Doi, Kiyoshi
    Yaku, Hitoshi
    Yutani, Chikao
    Kawamura, Takashi
    Kuno, Sadako
    Sawada, Hideyuki
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2009, 116 (02) : 171 - 178
  • [38] Pergolide: restrictive valvular heart disease not a rare finding?
    [J]. Reactions Weekly, 2004, 998 (1) : 6 - 6
  • [39] Pergolide pharmacokinetics in patients with Parkinson's disease (PD)
    Thalamas, C.
    Rajman, I.
    Bareille, M. P.
    Mackie, A.
    Soubrouillard, C.
    Kulisevsky, J.
    Descombes, S.
    Brefel-Courbon, C.
    Fabre, N.
    Barbanoj, M. J.
    Blin, O.
    Rascol, O.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 115 - 115
  • [40] High-dose oral intake of serotonin induces valvular heart disease in rabbits
    Lancellotti, Patrizio
    Nchimi, Alain
    Hego, Alexandre
    Dulgheru, Raluca
    Delvenne, Philippe
    Drion, Pierre
    Oury, Cecile
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 197 : 72 - 75
12345